Importantly, low levels of MOZ were demonstrated to be present in the M5 monocytic AML FAB subtype, correlating with inferior overall survival (OS) in retrospective data collected from the cancer genome atlas (TCGA) cohort (Jiang et al., 2019). The gene discussed is KAT6A; the disease is acute myeloid leukemia.